drugset / Trial / NCT06924684
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
Phase 2
Active not recruiting
66 enrolled
Sheikh Zayed Federal Postgraduate Medical Institute
Punjab Institute of Cardology · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the efficacy of high dose rosuvastatin preloading vs placebo before primary PCI in terms of MACE at 30 days
Timeline
- Start
- 2024-12-02
- Primary completion
- 2025-06-23
- Completion
- 2025-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | — | — |
| Comparator | Rosuvastatin | Small molecule | 20 mg | Oral |